Department of Radiology, University Hospital Regensburg, 93042, Regensburg, Germany.
MR Applications Predevelopment, Siemens Healthcare GmbH, Erlangen, Germany.
Eur Radiol. 2018 Sep;28(9):3591-3600. doi: 10.1007/s00330-018-5337-y. Epub 2018 Mar 12.
To determine whether liver function as determined by intravenous administration of C-methacetin and continuous real-time breath analysis can be estimated quantitatively from gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance (MR) relaxometry.
Sixty-six patients underwent a C-methacetin breath test (C-MBT) for evaluation of liver function and Gd-EOB-DTPA-enhanced T1-relaxometry at 3 T. A transverse 3D VIBE sequence with an inline T1 calculation based on variable flip angles was acquired prior to (T1 pre) and 20 min post-Gd-EOB-DTPA (T1 post) administration. The reduction rate of T1 relaxation time (rrT1) and T1 relaxation velocity index (∆R1) between pre- and post-contrast images was evaluated. C-MBT values were correlated with T1, ∆R1 and rrT1, providing an MRI-based estimated C-MBT value. The interobserver reliability was assessed by determining the intraclass correlation coefficient (ICC).
Stratified by three different categories of C-MBT readouts, there was a constant increase of T1 post with increasing progression of diminished liver function (p ≤ 0.030) and a constant significant decrease of ∆R1 (p ≤ 0.025) and rrT1 (p < 0.018) with progression of liver damage as assessed by C-methacetin breath analysis. ICC for all T1 relaxation values and indices was excellent (> 0.88). A simple regression model showed a log-linear correlation of C-MBT values with T1 (r = 0.57; p < 0.001), ∆R1 (r = 0.59; p < 0.001) and rrT1 (r = 0.70; p < 0.001).
Liver function as determined using real-time C-methacetin breath analysis can be estimated quantitatively from Gd-EOB-DTPA-enhanced MR relaxometry.
• Gd-EOB-DTPA-enhanced T1 relaxometry quantifies liver function • Gd-EOB-DTPA-enhanced MR relaxometry may provide parameters for assessing liver function before surgery • Gd-EOB-DTPA-enhanced MR relaxometry may be useful for monitoring liver disease progression • Gd-EOB-DTPA-enhanced MR relaxometry has the potential to become a novel liver function index.
通过静脉给予 C-美沙西丁和连续实时呼吸分析来定量评估钆塞酸(Gd-EOB-DTPA)增强磁共振(MR)弛豫率的肝功能。
66 例患者接受了 C-美沙西丁呼吸试验(C-MBT),以评估肝功能,并在 3T 下进行 Gd-EOB-DTPA 增强 T1 弛豫率。在注射 Gd-EOB-DTPA 之前(T1 预)和之后 20 分钟(T1 后)获得了一个横向 3D VIBE 序列,该序列基于可变翻转角进行了 T1 计算。评估了对比前后图像之间 T1 弛豫时间(rrT1)和 T1 弛豫速度指数(∆R1)的降低率。C-MBT 值与 T1、∆R1 和 rrT1 相关,提供了基于 MRI 的估计 C-MBT 值。通过确定组内相关系数(ICC)评估了观察者间的可靠性。
根据三种不同类别的 C-MBT 读数进行分层,随着肝功能减退的进展,T1 后值呈持续增加(p ≤ 0.030),而随着 C-美沙西丁呼吸分析评估的肝损伤进展,∆R1(p ≤ 0.025)和 rrT1(p <0.018)呈持续显著下降。所有 T1 弛豫值和指数的 ICC 均为优秀(>0.88)。简单回归模型显示 C-MBT 值与 T1(r = 0.57;p <0.001)、∆R1(r = 0.59;p <0.001)和 rrT1(r = 0.70;p <0.001)呈对数线性相关。
通过实时 C-美沙西丁呼吸分析确定的肝功能可以从 Gd-EOB-DTPA 增强的磁共振弛豫率中定量估计。
Gd-EOB-DTPA 增强 T1 弛豫率定量评估肝功能
Gd-EOB-DTPA 增强磁共振弛豫率可用于术前评估肝功能
Gd-EOB-DTPA 增强磁共振弛豫率可用于监测肝病进展
Gd-EOB-DTPA 增强磁共振弛豫率有可能成为新的肝功能指标